Literature DB >> 9618472

Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53.

X Zeng1, A J Levine, H Lu.   

Abstract

The transactivation activity of the p53 tumor suppressor protein is critical for regulating cell growth and apoptosis. We describe the identification of a transcription factor that is functionally similar to p53 and contains the same DNA binding and transcription activities specific for the p53 responsive DNA element (p53RE). This protein was highly purified through chromatography from HeLa cell extracts. The purified protein was able to bind specifically to the p53RE derived from a p21(waf1) promoter and to stimulate p53RE-dependent transcription but not basal transcription in vitro. Its DNA-binding activity was inhibited by the wild type but not mutant p53RE-containing DNA oligomers. Also, this p53RE-binding activity was found in human p53 null Saos-2 osteosarcoma and H1299 small cell lung carcinoma cells. Interestingly, this activity exhibited a p53RE sequence preference that was distinct from the p53 protein. The activity is neither p53 nor p73, because anti-p53 or anti-73 antibodies were unable to detect this purified protein nor were the antibodies able to alter the p53-like activity, the p53RE-protein complex. These results demonstrate that, besides p73, an additional p53-like protein exists in cells, which is named NBP for non-p53, p53RE binding protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618472      PMCID: PMC22597          DOI: 10.1073/pnas.95.12.6681

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  p53 in growth control and neoplasia.

Authors:  T M Gottlieb; M Oren
Journal:  Biochim Biophys Acta       Date:  1996-06-07

Review 2.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  p53 tagged sites from human genomic DNA.

Authors:  T Tokino; S Thiagalingam; W S el-Deiry; T Waldman; K W Kinzler; B Vogelstein
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

5.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.

Authors:  J Chen; X Wu; J Lin; A J Levine
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  Allosteric activation of latent p53 tetramers.

Authors:  T R Hupp; D P Lane
Journal:  Curr Biol       Date:  1994-10-01       Impact factor: 10.834

9.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein.

Authors:  H Lu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  10 in total

1.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.

Authors:  S Wienzek; J Roth; M Dobbelstein
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.

Authors:  X Zeng; X Li; A Miller; Z Yuan; W Yuan; R P Kwok; R Goodman; H Lu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  CK2 phosphorylates SSRP1 and inhibits its DNA-binding activity.

Authors:  Yanping Li; David M Keller; John D Scott; Hua Lu
Journal:  J Biol Chem       Date:  2005-01-18       Impact factor: 5.157

6.  SSRP1 functions as a co-activator of the transcriptional activator p63.

Authors:  Shelya X Zeng; Mu-Shui Dai; David M Keller; Hua Lu
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

7.  p63 induces key target genes required for epidermal morphogenesis.

Authors:  Maranke I Koster; Daisy Dai; Barbara Marinari; Yuji Sano; Antonio Costanzo; Michael Karin; Dennis R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

8.  A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M.

Authors:  Z Weng; A C Fluckiger; S Nisitani; M I Wahl; L Q Le; C A Hunter; A A Fernal; M M Le Beau; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 9.  Unraveling cancer lineage drivers in squamous cell carcinomas.

Authors:  Yinglu Guan; Guan Wang; Danielle Fails; Priyadharsini Nagarajan; Yejing Ge
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

Review 10.  Transcriptional and signalling regulation of skin epithelial stem cells in homeostasis, wounds and cancer.

Authors:  Yinglu Guan; Youn Joo Yang; Priyadharsini Nagarajan; Yejing Ge
Journal:  Exp Dermatol       Date:  2020-12-11       Impact factor: 3.960

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.